ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
116,700
-1,200 (-1.02%)
Jul 24, 2026, 3:30 PM KST

ST Pharm Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,436,3042,467,6411,790,0291,275,2351,647,6492,596,915
Market Cap Growth
27.52%37.85%40.37%-22.60%-36.55%34.10%
Enterprise Value
2,311,1952,427,6161,811,0531,375,6951,714,0242,628,966
Last Close Price
116700.00118825.8688620.9767198.7686117.30136081.99
PE Ratio
35.2344.8751.5765.1391.54784.06
Forward PE
31.8039.8836.2237.6967.19133.19
PS Ratio
7.047.446.544.476.6115.68
PB Ratio
3.994.163.563.304.837.97
P/TBV Ratio
4.104.283.683.445.078.37
P/FCF Ratio
37.79-67.18---
P/OCF Ratio
24.43176.4016.36982.17234.34357.22
PEG Ratio
1.030.960.620.740.484.96
EV/Sales Ratio
6.687.326.624.836.8815.87
EV/EBITDA Ratio
23.7628.6233.9924.3348.35131.50
EV/EBIT Ratio
35.3244.1965.4041.0596.02471.35
EV/FCF Ratio
35.85-67.97---
Debt / Equity Ratio
0.120.130.240.500.390.33
Debt / EBITDA Ratio
0.760.932.223.403.795.38
Debt / FCF Ratio
1.15-4.43---
Net Debt / Equity Ratio
-0.20-0.02-0.010.260.250.04
Net Debt / EBITDA Ratio
-1.28-0.14-0.051.802.380.72
Net Debt / FCF Ratio
-1.930.37-0.10-2.43-1.58-0.32
Asset Turnover
0.440.440.390.460.470.35
Inventory Turnover
1.191.341.461.541.721.75
Quick Ratio
1.101.151.432.530.823.00
Current Ratio
2.082.262.484.161.474.64
Return on Equity (ROE)
12.49%9.96%7.30%4.81%5.25%1.08%
Return on Assets (ROA)
5.14%4.56%2.48%3.36%2.09%0.74%
Return on Invested Capital (ROIC)
11.32%9.44%4.25%5.50%4.25%1.79%
Return on Capital Employed (ROCE)
10.30%8.90%4.70%5.70%4.60%1.30%
Earnings Yield
2.83%2.23%1.94%1.54%1.09%0.13%
FCF Yield
2.65%-1.34%1.49%-3.29%-3.24%-1.71%
Dividend Yield
0.42%0.42%----
Payout Ratio
14.60%18.32%27.09%48.03%52.25%-
Buyback Yield / Dilution
-9.10%-9.95%-3.70%--0.77%-0.05%
Total Shareholder Return
-8.68%-9.53%-3.70%--0.77%-0.05%